HRA's Rome office to launch morning-after pill in difficult market
This article was originally published in Scrip
Executive Summary
EllaOne (ulipristal acetate), HRA Pharma's emergency contraceptive, was approved for EU marketing in May under the centralised procedure, and the company is building a commercial presence throughout Europe to handle its launch.